DIAGNOSTICS

Groundbreaking Diagnostics research. Powered by the Anti-CRO.

Everything you need, expertly managed by one integrated team.

GET STARTED

See why our Diagnostics CRO customers give us a 4.85/5 satisfaction rating.

see case studies

"Our team was incredibly impressed with Lindus Health’s ability to recruit 90% of patients for a large clinical trial in just the first week. Their passion is evident in everything they do, and they really do hold value in creating better clinical trial experiences for patients."

Valentina Milanova

CEO

"Lindus Health’s approach to clinical trial execution and their associated technologies should be incredibly helpful to biotech and pharmaceutical companies and enable them to bring new therapies to market faster and more efficiently."

Prof Robert Langer

Founder, Moderna, 40+ Biotech companies

“Lindus puts great emphasis on aligning incentives with sponsors, and their risk-sharing, milestone-based payment model is much needed in the CRO industry. Their patient and technology-centric approach to clinical trials will greatly benefit biotech and pharma companies, enabling faster, cost-effective studies.”

Dr. Tim Garnett

Former CMO, Eli Lilly
AWARDS AND ACHIEVEMENTS

Award-winning Diagnostics CRO

LEARN WHY
OUR IMPACT

Proven results.

72.9% faster recruitment

Compared to benchmark rates of traditional CROs, powered by our novel recruitment techniques for medical device studies

Built by and for medical device experts

Backed by advisors, PIs, and clinical research teams with extensive experience in medical device trial design and execution.

Fixed costs, no budget overruns

Our business model aligns incentives and goals so you only pay when results are delivered.

OUR IMPACT

Proven results.

Cooking
Writing
Course
100
TOPICS
Writing
Writing
Course
100
TOPICS
Business
Business
Course
100
TOPICS
View RESOURCES
01

72.9% faster recruitment

Compared to benchmark rates of traditional CROs, powered by our novel recruitment techniques for diagnostic studies

No Delays
02

Experts in diagnostic innovation

From health monitors to oncology screening, our team of advisors and diagnostics researchers are experts in the complexities of these trials.

03

Fixed costs, no budget overruns

Our business model aligns incentives and goals so you only pay when results are delivered.

the problem

Goodbye fragmented oversight.

If you've ever worked with a traditional CRO, you know what it's like to piece together:

  • Trial Management
  • eClinical platform
  • Central Recruitment
  • Site Network
  • Virtual Site Solutions
the SOLUTION

Hello unified execution.

With Lindus, experience having everything you need all-in-one.

Let's chat

A recruitment model for every diagnostics study.

close icon

Oncology Diagnostics CRO

SEE HOW IT WORKS

        Our trusted experts are here to help you bring your liquid biopsy and cancer screening technologies to the hands of patients and clinicians faster than traditional CROs. From early feasibility to pivotal studies, we streamline trial design and execution to keep pace with the innovation you’re driving.

        close icon

        Infectious Disease Diagnostics CRO

        SEE HOW IT WORKS

              We’re deeply familiar with the unique demands of this critical area of research—including seasonality, regional epidemiology, and fluctuating transmission patterns. Our team understands how to design and operationalize studies that align with real-world disease dynamics, ensuring rapid enrollment and robust data capture when it matters most.

              Sep 4, 2025 11:00 AMEDT

              Optimizing Oncology Diagnostic Trials: Liquid Biopsy Validation and Market Approval

              Meri Profile Image
              REGISTER NOW

              IVDD to IVDR: A Sponsor’s Guide to Europe’s Diagnostic Revolution

              The transition from IVDD to IVDR represents the most significant regulatory change for diagnostic devices in Europe in decades. Understanding the evolving requirements is essential.

              READ NOW

              How to Build a Go-to-Market Strategy for Your IVD

              The global in vitro diagnostics (IVD) market is evolving rapidly, driven by growing demand for faster, more accessible testing across clinical and consumer settings.

              READ NOW
              GUIDE
              Get the guide
              GO TO DOWNLOAD
              Subscribe for more content
              Thank you! Your submission has been received!
              Oops! Something went wrong while submitting the form.
              Visit Our Resource Center
              ADVISORS

              Say hello to our Diagnostics CRO advisory board

              Ready to enjoy working with your Diagnostics CRO?

              Let’s deliver better clinical trials together to get new treatments to patients faster.

              Privacy policy

              Thank you! Your submission has been received!
              Oops! Something went wrong while submitting the form.

              Privacy policy